Literature DB >> 19797536

Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects.

Teresa Nunes1, Luis Almeida, José-Francisco Rocha, Amílcar Falcão, Carlos Fernandes-Lopes, Ana I Loureiro, Lyndon Wright, M Vaz-da-Silva, Patrício Soares-da-Silva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19797536     DOI： 10.1177/0091270009339191

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  39 in total

Review 1.  Bioavailability challenges associated with development of anti-cancer phenolics.

Authors:  Song Gao; Ming Hu
Journal:  Mini Rev Med Chem       Date:  2010-06       Impact factor: 3.862

2.  Modulatory effect of resveratrol on SIRT1, SIRT3, SIRT4, PGC1α and NAMPT gene expression profiles in wild-type adult zebrafish liver.

Authors:  Helena Schirmer; Talita Carneiro Brandão Pereira; Eduardo Pacheco Rico; Denis Broock Rosemberg; Carla Denise Bonan; Maurício Reis Bogo; André Arigony Souto
Journal:  Mol Biol Rep       Date:  2011-06-25       Impact factor: 2.316

3.  Analytical method development for synthesized conjugated metabolites of trans-resveratrol, and application to pharmacokinetic studies.

Authors:  Otito F Iwuchukwu; Satish Sharan; Daniel J Canney; Swati Nagar
Journal:  J Pharm Biomed Anal       Date:  2011-12-16       Impact factor: 3.935

Review 4.  Resveratrol--pills to replace a healthy diet?

Authors:  Veronique S Chachay; Carl M J Kirkpatrick; Ingrid J Hickman; Maree Ferguson; Johannes B Prins; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

Review 5.  Resveratrol for the Management of Diabetes and its Downstream Pathologies.

Authors:  Moola Joghee Nanjan; James Betz
Journal:  Eur Endocrinol       Date:  2014-02-28

6.  Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

Authors:  Ketan R Patel; Victoria A Brown; Donald J L Jones; Robert G Britton; David Hemingway; Andrew S Miller; Kevin P West; Tristan D Booth; Marjorie Perloff; James A Crowell; Dean E Brenner; William P Steward; Andreas J Gescher; Karen Brown
Journal:  Cancer Res       Date:  2010-09-14       Impact factor: 12.701

Review 7.  The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges.

Authors:  Mary Ndiaye; Carol Philippe; Hasan Mukhtar; Nihal Ahmad
Journal:  Arch Biochem Biophys       Date:  2011-01-04       Impact factor: 4.013

8.  Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis.

Authors:  Victoria A Brown; Ketan R Patel; Maria Viskaduraki; James A Crowell; Marjorie Perloff; Tristan D Booth; Grygoriy Vasilinin; Ananda Sen; Anna Maria Schinas; Gianfranca Piccirilli; Karen Brown; William P Steward; Andreas J Gescher; Dean E Brenner
Journal:  Cancer Res       Date:  2010-10-08       Impact factor: 12.701

9.  Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity.

Authors:  Alexandre Dal-Pan; Stéphane Blanc; Fabienne Aujard
Journal:  BMC Physiol       Date:  2010-06-22

Review 10.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.